These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 1123168

  • 1. [Effect on short-term memory of classic antitubercular drugs used in the treatment of tuberculosis].
    Oleszkiewicz Z.
    Gruzlica; 1975 Apr; 43(4):383-90. PubMed ID: 1123168
    [No Abstract] [Full Text] [Related]

  • 2. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M, Bek E.
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract] [Full Text] [Related]

  • 3. [Side effects of antibacterial drugs in the clinical course of pulmonary tuberculosis].
    Czkwianianc M, Markiewicz I.
    Przegl Lek; 1969 Jun 24; 25(6):479-81. PubMed ID: 5805095
    [No Abstract] [Full Text] [Related]

  • 4. Isoniazid-induced anaphylaxis.
    Crook MJ.
    J Clin Pharmacol; 2003 May 24; 43(5):545-6. PubMed ID: 12751276
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiological evidence of peripheral nerve damage in patients treated with isoniazid.
    Bahemuka M, Kioy PM, Wanjama M, Wainaina CM.
    East Afr Med J; 1982 Dec 24; 59(12):798-802. PubMed ID: 6191942
    [No Abstract] [Full Text] [Related]

  • 6. [Leukergy in patients with pulmonary tuberculosis treated for the first time with antitubercular drugs].
    Przemyska B.
    Gruzlica; 1967 Dec 24; 35(11):1169-74. PubMed ID: 6063620
    [No Abstract] [Full Text] [Related]

  • 7. [Lupus and related syndromes: rare complication of long treatments with isoniazid and other antitubercular drugs (apropos of 2 new cases)].
    Delepierre F, Rullière R, Coury C.
    Rev Tuberc Pneumol (Paris); 1971 Jun 24; 35(4):397-412. PubMed ID: 4108874
    [No Abstract] [Full Text] [Related]

  • 8. [Isoniazid-induced pleuro-pericarditis].
    Jouneau S, Volatron AC, Brinchault G, Morel V, Belleguic C, Delaval P.
    Rev Pneumol Clin; 2003 Dec 24; 59(6):357-9. PubMed ID: 14745341
    [Abstract] [Full Text] [Related]

  • 9. [The elimination of chemotherapy side effects in pulmonary tuberculosis patients].
    Bal'tseva LB, Mel'nik GV, Man'ko VP.
    Vrach Delo; 1990 Apr 24; (4):71-3. PubMed ID: 2275176
    [Abstract] [Full Text] [Related]

  • 10. [Rheumatic diseases caused by antitubercular drugs].
    Anastasatu C, Stoia I, Kaufman S, Ghenoiu O, Iancovici O.
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan 24; 136(1):51-63. PubMed ID: 4538033
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of antitubercular chemotherapy on immune status within the first 3 months of the start of short-term treatment].
    Cioflec D, Ion N, Tudorache V, Hudiţeanu O, Luţă V, Chira Z, Neagoe D, Stoienescu D, Jemna I, Sfetcu V.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988 Jan 24; 37(2):137-44. PubMed ID: 2849189
    [No Abstract] [Full Text] [Related]

  • 12. [Cooperative study of short-term antibacillary treatments in 14 French centers].
    Brouet G.
    Bull Int Union Tuberc; 1974 Jan 24; 49(1):398-410. PubMed ID: 4219734
    [No Abstract] [Full Text] [Related]

  • 13. [Recent-term therapeutic effects of short-course chemotherapy in rural outpatients with smear positive tuberculosis].
    Zhang YD.
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Feb 24; 9(1):6-8, 61. PubMed ID: 3743281
    [No Abstract] [Full Text] [Related]

  • 14. [Development of agranulocytosis in long-term treatment of tuberculosis with Ethoxyd in combination with other antitubercular agents].
    Gol'dberg AS, Medved' RI.
    Klin Med (Mosk); 1970 Dec 24; 48(12):43-7. PubMed ID: 5518596
    [No Abstract] [Full Text] [Related]

  • 15. [Electroencephalographic changes and antitubercular treatments].
    Piéron R, Gautier H, Duhurt J, Kauffmann JP.
    Sem Hop; 1972 Oct 08; 48(40):2585-91. PubMed ID: 4344846
    [No Abstract] [Full Text] [Related]

  • 16. [The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
    Borisova MI, Stakhanov VA, Sharkova TI, Ivashchenko NA.
    Probl Tuberk Bolezn Legk; 2003 Oct 08; (7):34-7. PubMed ID: 12939876
    [Abstract] [Full Text] [Related]

  • 17. [Phenotype of isoniazid acetylation and tolerance of antitubercular drugs].
    Gontsa FT, Savina LA, Tsurkan VP, Kovalenko IP.
    Probl Tuberk; 1988 Oct 08; (2):35-8. PubMed ID: 3375215
    [No Abstract] [Full Text] [Related]

  • 18. [Controlled intermittent chemotherapy with isoniazid and the second line preparations].
    Utkin VV, Zhukova GN, Shmeleva VI.
    Probl Tuberk; 1975 Oct 08; (6):22-6. PubMed ID: 1215343
    [No Abstract] [Full Text] [Related]

  • 19. [Adverse neurotoxic reactions of chemotherapy for tuberculosis and their treatment].
    Lysov AV, Mordyk AV, Zatvornitskiĭ VA, Kondria AV.
    Probl Tuberk Bolezn Legk; 2006 Oct 08; (9):45-8. PubMed ID: 17128801
    [Abstract] [Full Text] [Related]

  • 20. Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime.
    Nolan CM.
    Am J Respir Crit Care Med; 2003 Aug 15; 168(4):412-3. PubMed ID: 12912731
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.